Truth above all

Create your Newsoras account

Log in to Newsoras

Entertainment··2 min read·

Theranos Documentary Crosses $80 Million in North America

A24's three-hour film about Elizabeth Holmes is now the second-highest-grossing non-music documentary in the region.

Theranos Documentary Crosses $80 Million in North America
Image: Tima Miroshnichenko / Pexels — pexels

The film's performance shows that a documentary can compete commercially with big-budget studio releases, and it extends the public reckoning with Theranos and its founder well beyond the earlier books, series and films about the fraud.

A documentary powerhouse in its fourth weekend

After only four weekends in theaters, the A24 documentary about Theranos fraudster Elizabeth Holmes has reached $80 million in North America. Over its fourth frame it took $8.8 million from 2,473 theaters, a decline of just 23%, and it is on course to pass $100 million domestically, a notable result for a documentary running close to three hours.[S1]

That total places it second among non-music documentaries in North America, ahead of the 2005 film March of the Penguins at $77 million and behind Michael Moore's 2005 Fahrenheit 9/11 at $119 million. The film has not yet opened internationally; a staggered release begins at the end of November, and it will need strong foreign audiences to challenge the genre's worldwide records. Fahrenheit 9/11 remains the biggest documentary globally with $103 million overseas and $222 million worldwide, followed by March of the Penguins with $49 million abroad and $127 million globally.[S1]

Word of mouth and an unusual production

The film premiered unexpectedly at the Telluride Film Festival and became a word-of-mouth hit, helped by some of the year's strongest reviews. It opened to $15 million in mid-October and has kept drawing crowds, including viewers who returned to theaters to work through its stranger-than-fiction story. Directed by Nathan Fielder and Lance Oppenheim, it unfolds over three years and starts as Holmes, founder of the health technology company Theranos, prepares to serve an 11-year prison sentence for defrauding investors.[S1]

GO DEEPER WITH NEWSORAS

Understand this article deeper

Its turnout is striking given how much has already been made about Holmes. Her rise and fall were dramatized in the Hulu series The Dropout, starring Amanda Seyfried, and in Alex Gibney's film The Inventor: Out for Blood in Silicon Valley. Secrecy around the project, which was unknown until about a month before it reached theaters, raised anticipation, and the commercial draw of Fielder, known for blending reality and fiction in shows such as HBO's The Rehearsal and Comedy Central's Nathan For You, added to the curiosity.[S1]

Outgrossing bigger and costlier releases

The documentary has taken in more than several major fall releases, among them Oppenheim's Primetime, a drama with Robert Pattinson as To Catch a Predator host Chris Hansen, at $46 million so far; DC's Clayface at $56 million; Brad Pitt's survival thriller Heart of the Beast at $67 million; and the Colleen Hoover adaptation Verity, with Anne Hathaway and Dakota Johnson, at $75 million. Each of those films was backed by months of multimillion-dollar marketing.[S1]

For A24, the film is now the studio's third-biggest domestic release, ahead of 2022's Everything Everywhere All at Once at $77 million and behind this summer's Backrooms at $197 million and 2025's Marty Supreme at $96 million. With a production budget of $7 million, it is also set to be highly profitable.[S1][S3]

Sources: Variety · IMDB · Yahoo
Portrait of Oscar Wilde

Ask a Thinker about this article

GO DEEPER WITH NEWSORAS

Understand this article deeper

Comments

You'll comment as Anonymous. to comment with your username.
0/1500

Insults, spam and personal data are moderated.

    Log in to Newsoras

    Topics
    Elizabeth HolmesTheranosA24DocumentaryBox Office
    End of the story

    Still have a question?

    Write it and Newsoras AI answers with this story's context.

    Or hear from · Free, no card.

    About the author

    Editorial reviewer

    Adelo Vieira is part of the Newsoras editorial team and reviews stories before they go out.

    NEWSORAS Editorial

    We stand for deep, verifiable, multi-perspective journalism. Our systems combine human reportage from leading agencies with synthetic intelligence to expose structural drivers.

    Create your Newsoras account

    Your email and a password. No card.

    Your free account includes

    • 5 questions a month to Newsoras AI
    • 1 question a month to the thinker you choose
    • Plus one extra welcome question, to try a second one
    • Answers grounded in the article, with its sources

    At least 8 characters.

    Free forever. No credit card.

    Already have an account?